DNA hypomethylation in rheumatoid arthritis synovial fibroblasts

Arthritis and Rheumatism

Volumn 60, Issue 12, 2009, Pages 3613-3622

  Karouzakis, Emmanuel ^a   Gay, Renate E ^a   Michel, Beat A ^a   Gay, Steffen ^a   Neidhart, Michel ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Center of Experimental Rheumatology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLCYTOSINE; AZACITIDINE; BISULFITE; CELL ADHESION MOLECULE; COMPLEMENTARY DNA; CYTOKINE; DNA METHYLTRANSFERASE 1; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; SCLEROPROTEIN;

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; OSTEOARTHRITIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS; SEQUENCE ANALYSIS; SYNOVIOCYTE; SYNOVIUM; UPREGULATION; WESTERN BLOTTING;

ARTHRITIS, RHEUMATOID; AZACITIDINE; CELLS, CULTURED; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ENZYME INHIBITORS; FIBROBLASTS; GENE EXPRESSION; GENE SILENCING; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOARTHRITIS; SYNOVIAL MEMBRANE;

EID: 73249146755     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.25018     Document Type: Article

References (39)

1. Shealy DJ, Visvanathan S. Anti-TNF antibodies: lessons from the past, roadmap for the future. Handb Exp Pharmacol 2008;181: 101-29.
2. Karouzakis E, Neidhart M, Gay RE, Gay S. Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett 2006;106: 8-13.
3. Muller-Ladner U, Pap T, Gay RE, Neidhart M, Gay S. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Clin Pract Rheumatol 2005;1: 102-10.
4. Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Sporn MB, Wilder RL. Anchorage-independent growth of synoviocytes from arthritic and normal joints: stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-β and retinoids. J Clin Invest 1989;83:1267-76.
5. Muller-Ladner U, Kriegsmann J, Gay RE, Gay S. Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:675-90.
6. Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999;58:691-7.
7. Rinaldi N, Schwarz-Eywill M, Weis D, Leppelmann-Jansen P, Lukoschek M, Keilholz U, et al. Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins. Ann Rheum Dis 1997;56:45-51.
8. Firestein GS, Alvaro-Gracia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990;144:3347-53.
9. Esteller M. Epigenetics in cancer [review]. N Engl J Med 2008; 358:1148-59.
10. Turek-Plewa J, Jagodzinski PP. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett 2005;10:631-47.
11. Schulz WA, Steinhoff C, Florl AR. Methylation of endogenous human retroelements in health and disease. Curr Top Microbiol Immunol 2006;310:211-50.
12. Neidhart M, Rethage J, Kuchen S, Kunzler P, Crowl RM, Billingham ME, et al. Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum 2000;43:2634-47.
13. Ali M, Veale DJ, Reece RJ, Quinn M, Henshaw K, Zanders ED, et al. Overexpression of transcripts containing LINE-1 in the synovia of patients with rheumatoid arthritis. Ann Rheum Dis 2003;62:663-6.
14. Hmadcha A, Bedoya FJ, Sobrino F, Pintado E. Methylation-dependent gene silencing induced by interleukin 1β via nitric oxide production. J Exp Med 1999;190:1595-604.
15. Wehbe H, Henson R, Meng F, Mize-Berge J, Patel T. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Res 2006;66:10517-24.
16. Szyf M. The role of DNA methyltransferase 1 in growth control. Front Biosci 2001;6:D599-609.
17. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007;1775:138-62.
18. Takami N, Osawa K, Miura Y, Komai K, Taniguchi M, Shiraishi M, et al. Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthritis Rheum 2006;54:779-87.
19. Neidhart M, Zaucke F, von Knoch R, Jungel A, Michel BA, Gay RE, et al. Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix protein. Ann Rheum Dis 2005;64:419-24.
20. Wang AZ, Wang JC, Fisher GW, Diamond HS. Interleukin-1β-stimulated invasion of articular cartilage by rheumatoid synovial fibroblasts is inhibited by antibodies to specific integrin receptors and by collagenase inhibitors. Arthritis Rheum 1997;40: 1298-307.
21. Solan NJ, Ward PE, Sanders SP, Towns MC, Bathon JM. Soluble recombinant neutral endopeptidase (CD10) as a potential antiinflammatory agent. Inflammation 1998;22:107-21.
22. Schett G. Immune cells and mediators of inflammatory arthritis [review]. Autoimmunity 2008;41:224-9.
23. Wahl AF, Wallace PM. Oncostatin M in the anti-inflammatory response. Ann Rheum Dis 2001;60 Suppl 3:iii75-80.
24. Solau-Gervais E, Zerimech F, Lemaire R, Fontaine C, Huet G, Flipo RM. Cysteine and serine proteases of synovial tissue in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 2007; 36:373-7.
25. Masuda K, Masuda R, Neidhart M, Simmens BR, Michel BA, Muller-Ladner U, et al. Molecular profile of synovial fibroblasts in rheumatoid arthritis depends on the stage of proliferation. Arthritis Res 2002;4:R8.
26. Rutkauskaite E, Volkmer D, Shigeyama Y, Schedel J, Pap G, Muller-Ladner U, et al. Retroviral gene transfer of an antisense construct against membrane type 1 matrix metalloproteinase reduces the invasiveness of rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2005;52:2010-4.
27. Sato N, Maehara N, Su GH, Goggins M. Effects of 5-aza-2′- deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness. J Natl Cancer Inst 2003;95:327-30.
28. Bira Y, Tani K, Nishioka Y, Miyata J, Sato K, Hayashi A, et al. Transforming growth factor β stimulates rheumatoid synovial fibroblasts via the type II receptor. Mod Rheumatol 2005;15: 108-13.
29. Khan M, Pelengaris S, Cooper M, Smith C, Evan G, Betteridge J. Oxidised lipoproteins may promote inflammation through the selective delay of engulfment but not binding of apoptotic cells by macrophages. Atherosclerosis 2003;171:21-9.
30. Vallejo AN, Mugge LO, Klimiuk PA, Weyand CM, Goronzy JJ. Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells. J Immunol 2000;164:2947-54.
31. Okroj M, Heinegard D, Holmdahl R, Blom AM. Rheumatoid arthritis and the complement system. Ann Med 2007;39:517-30.
32. Hummel KM, Petrow PK, Franz JK, Muller-Ladner U, Aicher WK, Gay RE, et al. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol 1998;25:1887-94.
33. Kobayashi Y, Ichijo Y, Nagatake H, Watanabe N, Nishizawa K, Goto M. Processing of interleukin-1 β in synovial cells freshly isolated from patients with rheumatoid arthritis. Biochem Biophys Res Commun 1994;199:1035-4
34. Jacques C, Gosset M, Berenbaum F, Gabay C. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. Vitam Horm 2006;74:371-403.
35. Van Bilsen JH, van Dongen H, Lard LR, van der Voort EI, Elferink DG, Bakker AM, et al. Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis. Proc Natl Acad Sci U S A 2004;101:17180-5.
36. Schmelz K, Sattler N, Wagner M, Lubbert M, Dorken B, Tamm I. Induction of gene expression by 5-Aza-2′-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and independent mechanisms. Leukemia 2005;19:103-11.
37. Liang G, Gonzales FA, Jones PA, Orntoft TF, Thykjaer T. Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-Aza-2′-deoxycytidine. Cancer Res 2002;62:961-6.
38. Nguyen CT, Weisenberger DJ, Velicescu M, Gonzales FA, Lin JC, Liang G, et al. Histone H3-Lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-Aza-2′-deoxycytidine. Cancer Res 2002;62:6456-61.
39. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, Blanco D, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 2008;105:13556-61.